Search

Vielversprechender Prognose- und Therapie-Ansatz bei Mastozytose ...Uni Vienna und Lukas Kenner (Klinisches Institut für Pathologie) konnte außerdem gezeigt werden, dass CCL-2 für das Wachstum von Mastzelltumoren wesentlich ist. Für die Behandlung von Brust- und Prostatakarzinomen, wo ebenfalls erhöhte CCL-2-Spiegel vorliegen, werden bereits Antikörper getestet, die... https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2016/news-im-dezember-2016/vielversprechender-prognose-und-therapie-ansatz-bei-mastozytose/

Vielversprechender Prognose- und Therapie-Ansatz bei Mastozytose ...Uni Vienna und Lukas Kenner (Klinisches Institut für Pathologie) konnte außerdem gezeigt werden, dass CCL-2 für das Wachstum von Mastzelltumoren wesentlich ist. Für die Behandlung von Brust- und Prostatakarzinomen, wo ebenfalls erhöhte CCL-2-Spiegel vorliegen, werden bereits Antikörper getestet, die... https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2016/news-im-dezember-2016/vielversprechender-prognose-und-therapie-ansatz-bei-mastozytose/medizin-wissenschaft/

Emine Atas receives Youth Travel Funds Award of the FEBS ...D student at the Clinical Institute of Pathology at MedUni Vienna (Lukas Kenner resarch group) and is working on a project on the role of PDK4 in prostate carcinoma tumorigenesis. Share Whatsapp Facebook LinkedIn Xing Mail BlueSky All News... https://www.meduniwien.ac.at/web/en/about-us/news/2023/news-in-september-2023/emine-atas-receives-youth-travel-funds-award-of-the-febs/

Emine Atas receives Youth Travel Funds Award of the FEBS ...D student at the Clinical Institute of Pathology at MedUni Vienna (Lukas Kenner resarch group) and is working on a project on the role of PDK4 in prostate carcinoma tumorigenesis. Share Whatsapp Facebook LinkedIn Xing Mail BlueSky All News... https://www.meduniwien.ac.at/web/en/about-us/news/2023/news-in-september-2023/emine-atas-receives-youth-travel-funds-award-of-the-febs/people-of-the-meduni-vienna/

News .... Dr. Lukas Kenner, Medizinische Universität Wien, beschäftigt sich seit einiger Zeit mit hoch malignen Lymphomen (bösartigen Tumoren der Lymphknoten), die gehäuft auch bei Kindern auftreten. Für Lymphome typisch ist die krankhafte Verknüpfung von Chromosomen, die sonst nicht miteinander verbundene... https://www.meduniwien.ac.at/web/ueber-uns/news/detail/neue-therapieansaetze-fuer-lymphknotenkrebs/

Epigenetics provides new insights into the pathogenesis of lymphoma ... of Cambridge and the University of Southern California (USC), molecular biologist Melanie Hassler from the working group led by Gerda Egger (Department of Pathology at MedUni Vienna, Division of Experimental Pathology, Head: Lukas Kenner) has analysed the methylation pattern of Anaplastic Large Cell... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2016/news-in-october-2016/epigenetics-provides-new-insights-into-the-pathogenesis-of-lymphoma/medicine-science/

Epigenetics provides new insights into the pathogenesis of lymphoma ... of Cambridge and the University of Southern California (USC), molecular biologist Melanie Hassler from the working group led by Gerda Egger (Department of Pathology at MedUni Vienna, Division of Experimental Pathology, Head: Lukas Kenner) has analysed the methylation pattern of Anaplastic Large Cell... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2016/news-in-october-2016/epigenetics-provides-new-insights-into-the-pathogenesis-of-lymphoma/

2026 Juni - Emine Atas | MedUni Wien ... Pioglitazone inhibits cell proliferation and induces metabolic reprogramming in prostate cancer“ [1]. Die multidisziplinäre Studie entstand im Rahmen des PhD-Studiums von Emine Atas, PhD am Klinischen Institut für Pathologie in der Arbeitsgruppe von Univ.-Prof. Dr. Lukas Kenner in Kollaboration mit nationalen... https://www.meduniwien.ac.at/web/forschung/researcher-of-the-month/2026/2026-juni-emine-atas/

Study reveals new therapeutic option for head and neck carcinomas ... leader Lorenz Kadletz-Wanke, summarising the key finding of the research, which was conducted at MedUni Vienna's Department of Otorhinolaryngology and Head and Neck Surgery in collaboration with Lukas Kenner (MedUni Vienna's Department of Pathology, Department of Laboratory Animal Pathology at Vetmeduni Vienna) and Stefan Stoiber (MedUni Vienna's Department of Biomedical Imaging and Image-guided Therapy). Service: Pharmaceuticals Targeting Wnt/Beta-Catenin Signaling in HPV-Positive Head and Neck Squamous Cell Carcinoma. Brkic FF, Stoiber S, Maier T, Gurnhofer E, Kenner L, Heiduschka G, Kadletz-Wanke L... https://www.meduniwien.ac.at/web/en/ueber-uns/news/default-0f889c8985-2/studie-zeigt-neue-therapieoption-bei-kopf-halstumoren-auf/

Study reveals new therapeutic option for head and neck carcinomas ... leader Lorenz Kadletz-Wanke, summarising the key finding of the research, which was conducted at MedUni Vienna's Department of Otorhinolaryngology and Head and Neck Surgery in collaboration with Lukas Kenner (MedUni Vienna's Department of Pathology, Department of Laboratory Animal Pathology at Vetmeduni Vienna) and Stefan Stoiber (MedUni Vienna's Department of Biomedical Imaging and Image-guided Therapy). Service: Pharmaceuticals Targeting Wnt/Beta-Catenin Signaling in HPV-Positive Head and Neck Squamous Cell Carcinoma. Brkic FF, Stoiber S, Maier T, Gurnhofer E, Kenner L, Heiduschka G, Kadletz-Wanke L... https://www.meduniwien.ac.at/web/en/ueber-uns/news/default-0f889c8985-2/studie-zeigt-neue-therapieoption-bei-kopf-halstumoren-auf/medicine-science/

Persons

Webseiten-Inhalte